ARCHIVES

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

This article is from The Cancer Letter archive.

Vol. 29 No. 25 | June 20, 2003

Download PDF Visit The Full Archive

Related Articles

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

Chop Analysis Shows Program Had Major Impact In Communities

January 25, 1985

In Brief: Marasco New ACR President, Barbara Chick VP; Wolmark Named Surgeon In Chief Of Montefiore

October 10, 1986

Chemo, Radiation Improves DFS In Head & Neck Cancer

May 28, 2004

Therapeutic Vaccine May Fight Pancreatic Cancer

February 23, 2007

NCI Bypass Budget Calls For $5.98 Billion

December 6, 2002